BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HRS-6208 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HRS-6208\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06568094-11084@assetmemo.bio
DTSTAMP:20261121T005728Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:HRS-6208: Phase 1/2 readout est. (NCT06568094)
DESCRIPTION:HRS-6208\, phase 1/2.\nStudy: A Study of HRS-5041 Tablets Combi
 ned With Antitumor Therapy in Subjects With Advanced Prostate Cancer\nEsti
 mated primary completion: December 2026. This is a ClinicalTrials.gov esti
 mate\, not a confirmed readout date\, and it can move.\nDrug page: https:/
 /assetmemo.bio/drug/hrs-6208#upcoming-events\nRegistry record: https://cli
 nicaltrials.gov/study/NCT06568094
URL:https://assetmemo.bio/drug/hrs-6208#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06727812-11084@assetmemo.bio
DTSTAMP:20261121T005728Z
DTSTART;VALUE=DATE:20270831
DTEND;VALUE=DATE:20270901
SUMMARY:HRS-6208: Phase 1 readout est. (NCT06727812)
DESCRIPTION:HRS-6208\, phase 1.\nStudy: Multicenter Phase I Study of HRS-62
 08 in Patients With Solid Tumors\nEstimated primary completion: August 202
 7. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, 
 and it can move.\nDrug page: https://assetmemo.bio/drug/hrs-6208#upcoming-
 events\nRegistry record: https://clinicaltrials.gov/study/NCT06727812
URL:https://assetmemo.bio/drug/hrs-6208#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07389733-11084@assetmemo.bio
DTSTAMP:20261121T005728Z
DTSTART;VALUE=DATE:20281231
DTEND;VALUE=DATE:20290101
SUMMARY:HRS-6208: Phase 1/2 readout est. (NCT07389733)
DESCRIPTION:HRS-6208\, phase 1/2\, Breast Cancer.\nStudy: A Study of HRS-62
 08 in Combination With HRS-8080\, or Fulvestrant\, or Letrozole\, With or 
 Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Brea
 st Cancer\nEstimated primary completion: December 2028. This is a Clinical
 Trials.gov estimate\, not a confirmed readout date\, and it can move.\nDru
 g page: https://assetmemo.bio/drug/hrs-6208#upcoming-events\nRegistry reco
 rd: https://clinicaltrials.gov/study/NCT07389733
URL:https://assetmemo.bio/drug/hrs-6208#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
